Qualigen Therapeutics (QLGN) Short Interest Ratio & Short Volume $3.64 -0.21 (-5.45%) As of 04/24/2025 03:59 PM Eastern Add Compare Share Share Short Interest Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Qualigen Therapeutics Short Interest DataQualigen Therapeutics (QLGN) has a short interest of 119,500 shares, representing 17.44% of the float (the number of shares available for trading by the public). This marks a 70.47% increase in short interest from the previous month. The short interest ratio (days to cover) is 1.6, indicating that it would take 1.6 days of the average trading volume of 111,788 shares to cover all short positions.Current Short Interest119,500 sharesPrevious Short Interest70,100 sharesChange Vs. Previous Month+70.47%Dollar Volume Sold Short$434,980.00Short Interest Ratio1.6 Days to CoverLast Record DateMarch 31, 2025Outstanding Shares736,000 sharesFloat Size685,200 sharesShort Percent of Float17.44%Today's Trading Volume113,815 sharesAverage Trading Volume111,788 sharesToday's Volume Vs. Average102% Short Selling Qualigen Therapeutics? Sign up to receive the latest short interest report for Qualigen Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartQLGN Short Interest Over TimeQLGN Days to Cover Over TimeQLGN Percentage of Float Shorted Over Time Qualigen Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 3/31/2025119,500 shares $434,980.00 +70.5%17.4%1.6 $3.64 3/15/202570,100 shares $214,506.00 -6.9%10.2%1.6 $3.06 2/28/202575,300 shares $238,701.00 -15.3%11.0%1.5 $3.17 2/15/202588,900 shares $329,730.10 -14.4%13.0%1.5 $3.71 1/31/2025103,800 shares $339,426.00 +49.4%15.2%1.5 $3.27 1/15/202569,500 shares $274,525.00 -20.4%10.1%0.7 $3.95 12/31/202487,300 shares $367,533.00 -10.7%12.7%0.9 $4.21 12/15/202497,800 shares $378,486.00 -2.4%14.3%1.1 $3.87 11/30/2024100,200 shares $462,924.00 +6.1%15.0%1.2 $4.62 11/15/202494,400 shares $339,840.00 +505.1%14.1%1.1 $3.60 Get the Latest News and Ratings for QLGN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Qualigen Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 10/31/202415,600 shares $76,908.00 -85.8%3.1%0.2 $4.93 10/15/2024110,200 shares $17,951.58 +1.1%0.5%0.2 $0.16 9/30/2024109,000 shares $18,584.50 -60.5%0.5%0 $0.17 9/15/2024275,600 shares $45,363.76 -55.1%1.3%0 $0.16 8/31/2024613,400 shares $115,073.84 +84.4%2.4%0 $0.19 8/15/2024332,600 shares $65,522.20 +38.8%2.9%0 $0.20 7/31/2024239,600 shares $53,263.08 -94.2%2.4%0 $0.22 7/15/20244,160,000 shares $1.61 million +627.9%40.9%0.3 $0.39 6/30/2024571,500 shares $98,469.45 +493.5%6.7%0.1 $0.17 6/15/202496,300 shares $19,163.70 +20.7%1.6%0.1 $0.20 5/31/202479,800 shares $21,546.00 +1.7%1.3%0.5 $0.27 5/15/202478,500 shares $24,083.80 +82.1%1.3%0.8 $0.31 4/30/202443,100 shares $12,921.38 -12.8%0.8%0.6 $0.30 4/15/202449,400 shares $15,808.00 -38.2%0.9%0.8 $0.32 3/31/202479,900 shares $31,960.00 +588.8%1.7%1.3 $0.40 3/15/202411,600 shares $4,294.32 +11.5%0.3%0.2 $0.37 2/29/202410,400 shares $4,785.04 -63.5%0.2%0.2 $0.46 2/15/202428,500 shares $13,523.25 -3.1%0.6%0.7 $0.47 1/31/202429,400 shares $15,452.64 -14.5%0.6%1.1 $0.53 1/15/202434,400 shares $17,595.60 +63.8%0.8%1.3 $0.51 12/31/202321,000 shares $11,550.00 -32.7%0.5%0.9 $0.55 12/15/202331,200 shares $18,033.60 -8.0%0.7%1.6 $0.58 11/30/202333,900 shares $25,052.10 -15.9%0.7%2.5 $0.74 11/15/202340,300 shares $28,250.30 +0.8%0.9%2.7 $0.70 10/31/202340,000 shares $31,108.00 +5.5%0.9%2.7 $0.78 10/15/202337,900 shares $35,091.61 -14.5%0.9%1.9 $0.93 9/30/202344,300 shares $44,743.00 +23.1%1.0%1.7 $1.01 9/15/202336,000 shares $37,800.00 +77.3%0.8%1.4 $1.05 8/31/202320,300 shares $21,112.00 -9.8%0.5%0.8 $1.04 8/15/202322,500 shares $24,525.00 -37.0%0.5%0.9 $1.09Trump Treasure April 19 (Ad)Thanks to President Trump… A $900 investment across5 specific cryptos… Could gain 12,000% so quickly that, just 12 months later…If I’m right about this (like I was before) a modest $900 investment… 7/31/202335,700 shares $40,341.00 +28.4%0.8%1.2 $1.13 7/15/202327,800 shares $30,749.58 -12.3%0.6%1.1 $1.11 6/30/202331,700 shares $28,878.70 +26.3%0.7%1.1 $0.91 6/15/202325,100 shares $24,098.51 -38.6%0.6%0.7 $0.96 5/31/202340,900 shares $37,746.61 +7.4%0.9%0.2 $0.92 5/15/202338,100 shares $38,862.00 -39.9%0.9%0.2 $1.02 4/30/202363,400 shares $59,507.24 -5.4%1.5%0.4 $0.94 4/15/202367,000 shares $63,650.00 -19.2%1.8%0.4 $0.95 3/31/202382,900 shares $76,690.79 +48.8%2.2%0.2 $0.93 3/15/202355,700 shares $56,257.00 -31.0%1.5%0.2 $1.01 2/28/202380,700 shares $92,466.06 +41.6%2.1%0.3 $1.15 2/15/202357,000 shares $70,965.00 -17.2%1.5%0.2 $1.25 1/31/202368,800 shares $88,752.00 -61.2%1.8%0.3 $1.29 1/15/2023177,200 shares $237,448.00 +84.8%4.6%0.8 $1.34 12/30/202295,900 shares $123,615.10 No Change2.5%0.5 $1.29 12/15/202295,900 shares $136,178.00 +18.1%2.5%3.7 $1.42 11/30/202281,200 shares $121,597.00 -11.8%2.1%3.1 $1.50 11/15/202292,100 shares $20,308.05 -90.0%N/A4.3 $0.22 10/31/2022916,300 shares $201,586.00 -2.7%N/A4.3 $0.22 10/15/2022941,700 shares $253,128.96 -15.9%N/A4 $0.27 9/30/20221,120,000 shares $299,040.00 +25.5%N/A4.7 $0.27 9/15/2022892,200 shares $291,927.84 -11.7%N/A3.6 $0.33 8/31/20221,010,000 shares $384,406.00 -1.0%N/A4.3 $0.38 8/15/20221,020,000 shares $433,500.00 -8.9%N/A4.5 $0.43 7/31/20221,120,000 shares $469,056.00 -2.6%N/A4.8 $0.42 7/15/20221,150,000 shares $535,670.00 -2.5%N/A5.1 $0.47 6/30/20221,180,000 shares $672,246.00 -9.9%N/A1 $0.57 6/15/20221,310,000 shares $793,467.00 -9.0%N/A1.2 $0.61 5/31/20221,440,000 shares $807,840.00 +2.1%N/A1.3 $0.56 5/15/20221,410,000 shares $751,530.00 +13.7%N/A1.2 $0.53 4/30/20221,240,000 shares $706,800.00 -43.9%N/A1.1 $0.57 4/15/20222,210,000 shares $1.60 million +63.7%N/A1.8 $0.73 3/31/20221,350,000 shares $891,000.00 +3.9%N/A3.9 $0.66 3/15/20221,300,000 shares $741,000.00 -3.7%N/A0.7 $0.57 2/28/20221,350,000 shares $891,000.00 +2.3%N/A0.6 $0.66 2/15/20221,320,000 shares $970,860.00 -7.0%N/A0.2 $0.74 1/31/20221,420,000 shares $1.24 million -7.8%N/A0.2 $0.87 1/15/20221,540,000 shares $1.62 million -36.1%5.8%0.2 $1.05 12/31/20212,410,000 shares $2.58 million +33.9%9.3%0.3 $1.07 12/15/20211,800,000 shares $1.74 million -68.4%6.9%0.2 $0.96 11/30/20215,700,000 shares $8.38 million +258.5%22.1%0.8 $1.47 11/15/20211,590,000 shares $1.70 million -7.0%6.2%0.3 $1.07 10/29/20211,710,000 shares $1.97 million +4.3%6.7%3.8 $1.15 10/15/20211,640,000 shares $1.92 million -0.6%6.4%3.7 $1.17 9/30/20211,650,000 shares $2.15 million -0.6%6.4%3.5 $1.30 9/15/20211,660,000 shares $2.39 million +16.9%6.5%3.3 $1.44 8/31/20211,420,000 shares $2.23 million -18.9%5.5%2.7 $1.57 8/13/20211,750,000 shares $3.12 million -1.1%6.8%5.2 $1.78 7/30/20211,770,000 shares $3.13 million +2.3%6.9%5 $1.77 7/15/20211,730,000 shares $2.92 million +4.2%6.8%3.4 $1.69Trump Treasure April 19 (Ad)Thanks to President Trump… A $900 investment across5 specific cryptos… Could gain 12,000% so quickly that, just 12 months later…If I’m right about this (like I was before) a modest $900 investment… 6/30/20211,660,000 shares $3.30 million +9.2%6.5%2.7 $1.99 6/15/20211,520,000 shares $3.19 million -16.0%6.0%2.3 $2.10 5/28/20211,810,000 shares $3.46 million +0.6%7.1%2.5 $1.91 5/14/20211,800,000 shares $2.75 million -6.3%7.1%2.1 $1.53 4/30/20211,920,000 shares $4.22 million +7.9%7.5%1.6 $2.20 4/15/20211,780,000 shares $3.65 million No Change6.3%1.1 $2.05 3/31/20211,780,000 shares $4.63 million -11.4%6.2%1.1 $2.60 3/15/20212,010,000 shares $6.69 million +24.8%7.6%1.2 $3.33 2/26/20211,610,000 shares $5.47 million -10.6%6.1%0.8 $3.40 2/12/20211,800,000 shares $6.98 million -9.6%6.8%1 $3.88 1/29/20211,990,000 shares $7.12 million +3.7%7.5%1.2 $3.58 1/15/20211,920,000 shares $6.62 million No Change7.3%1.5 $3.45 QLGN Short Interest - Frequently Asked Questions What is Qualigen Therapeutics' current short interest? Short interest is the volume of Qualigen Therapeutics shares that have been sold short but have not yet been covered or closed out. As of March 31st, investors have sold 119,500 shares of QLGN short. 17.44% of Qualigen Therapeutics' shares are currently sold short. Learn More on Qualigen Therapeutics' current short interest. What is a good short interest ratio for Qualigen Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. QLGN shares currently have a short interest ratio of 2.0. Learn More on Qualigen Therapeutics's short interest ratio. Which institutional investors are shorting Qualigen Therapeutics? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Qualigen Therapeutics: Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Qualigen Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 17.44% of Qualigen Therapeutics' floating shares are currently sold short. Is Qualigen Therapeutics' short interest increasing or decreasing? Qualigen Therapeutics saw a increase in short interest in March. As of March 31st, there was short interest totaling 119,500 shares, an increase of 70.5% from the previous total of 70,100 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Qualigen Therapeutics' float size? Qualigen Therapeutics currently has issued a total of 736,000 shares. Some of Qualigen Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Qualigen Therapeutics currently has a public float of 685,200 shares. How does Qualigen Therapeutics' short interest compare to its competitors? 17.44% of Qualigen Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Qualigen Therapeutics: Portage Biotech Inc. (50.72%), Flora Growth Corp. (4.36%), Ainos, Inc. (9.15%), Talphera, Inc. (0.42%), Citius Pharmaceuticals, Inc. (7.72%), NextCure, Inc. (0.27%), Turnstone Biologics Corp. (2.52%), Aprea Therapeutics, Inc. (1.25%), Carisma Therapeutics, Inc. (2.32%), Acurx Pharmaceuticals, Inc. (2.45%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($21.93 billion), iShares 20+ Year Treasury Bond ETF ($9.31 billion), Strategy Incorporated ($8.42 billion), Charter Communications, Inc. ($4.52 billion), Apollo Global Management, Inc. ($4.26 billion), Super Micro Computer, Inc. ($3.98 billion), Capital One Financial Co. ($3.79 billion), TC Energy Co. ($3.43 billion), AppLovin Co. ($2.91 billion), and Schlumberger Limited ($2.89 billion). View all of the most shorted stocks. What does it mean to sell short Qualigen Therapeutics stock? Short selling QLGN is an investing strategy that aims to generate trading profit from Qualigen Therapeutics as its price is falling. QLGN shares are trading down $0.21 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Qualigen Therapeutics? A short squeeze for Qualigen Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of QLGN, which in turn drives the price of the stock up even further. How often is Qualigen Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including QLGN, twice per month. The most recent reporting period available is March, 31 2025. More Short Interest Resources from MarketBeat Related Companies Portage Biotech Short Interest Data Flora Growth Short Interest Data Ainos Short Interest Data Talphera Short Interest Data Citius Pharmaceuticals Short Interest Data NextCure Short Interest Data Turnstone Biologics Short Interest Data Aprea Therapeutics Short Interest Data Carisma Therapeutics Short Interest Data Acurx Pharmaceuticals Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:QLGN) was last updated on 4/25/2025 by MarketBeat.com Staff From Our PartnersElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | Sponsored[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored"I'm risking my reputation on this"I've discovered something so significant about the 2025 crypto market that I had to put everything else aside ...Crypto 101 Media | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Qualigen Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Qualigen Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
